Precancerous lesions of cervix among women infected with HIV in Referral Hospitals of Amhara Region, Northwest Ethiopia: a cross sectional study by Kassa, Limenih Simachew et al.
Precancerous lesions of  cervix among women infected with HIV in Referral Hospitals 
of  Amhara Region, Northwest Ethiopia: a cross sectional study
 Limenih Simachew Kassa1, Worke Mulugeta Dile2, Gebresilasie Kahsay Zenebe3, Abadi Marta Berta3 
 
1. Department of  Midwifery, College of  Health Sciences, Bahir Dar University.
2. Department of  Midwifery, College of  Health Sciences, Debre Tabor University.
3. Department of  Midwifery, College of  Medicine and Health Sciences, University of  Gondar.
Abstract
Background: The risk of  death from complications related to cancer of  the cervix is a main health problem over the course of  
a woman’s life in low income countries. It commonly affects women infected with HIV. Therefore, screening women infected 
with HIV should start in low income countries, including Ethiopia. 
Methods: We conducted an institution based cross-sectional study from September 1st, 2015 to December 30th, 2015. During 
the study, 435 women were included in the study. The data were collected through face to face interviews and patient chart re-
view using pre-tested and structured questionnaires. Data was also collected through visual inspection with acetic acid applied 
for screening and treatment. Data was entered into Epi-info version 7, cleaned and analyzed using SPSS version 20. Logistic 
regression analysis fitted and odds ratio with 95% confidence interval were computed.
Results: The overall prevalence of  pre-cancerous lesions of  the cervix was 20.2% (95%CI: 13%, 29%). Having more than one 
lifetime sexual partner (AOR=2.91, 95%CI:1.13, 7.52), a history of  sexually transmitted disease (AOR=4.04, 95%CI: 2.19, 7.44), 
age at first birth less than 18 years (AOR=3.36, 95%CI: 1.79, 5.01) and baseline CD4 count less than 200 cells/mm3 (AOR=7.51, 
95%CI: 3.58, 15.68)  were significantly associated with pre-cancerous lesion of  the cervix.
Conclusion: This study points out the prevalence of  pre-cancerous lesions of  the cervix is high. Thus, the findings recommend 
raising of  a screening strategy for cervical intraepithelial neoplasia for all women living with HIV should be undertaken. In ad-
dition, awareness creation about the impact of  multiple sexual partner, promotion of  early HIV diagnosis and timely baseline 
CD4 cell count is important.
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Invasive cancer of  the cervix (ICC) is a result of  spread 
from the superficial part of  the cervix to tissues deeper 
in the cervix or to other parts of  the body . Worldwide, 
ICC is the third
commonest cancer in women1,2. Though it is treatable, it 
remains a principal reason for death among women living 
in resource limited countries3. Worldwide, it has an oc-
currence rate of  371,000 cases and death rate of  190,000 
with 80% of  the cancer of  the cervix death occurring in 
resource limited countries. The maximum rates are found 
in Central and South America, East Africa, South and-
South-East Asia and the Western Pacific. The problem is 
mainly worse in sub- Saharan Africa4. The age-adjusted 
incidence rate of  cancer of  the cervix in Ethiopia is 35.9 
per 100,000 women. From the time of  beginning of  the 
Human Immunodeficiency Virus (HIV) epidemic, cancer 
of  the cervix was categorized as an acquired immuno-
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deficiency syndrome (AIDS) defining cancer5,6,7. Stud-
ies revealed that the prevalence of  cytologically noticed 
squamous intraepithelial lesion (SIL) and infection of  the 
cervix with human papillomavirus (HPV) are suggestive-
ly more common in women infected with HIV. Further-
more, unlike other AIDS-defining cancers, the incidence 
of  cancer of  the cervix has not reduced considerably with 
the growing use of  antiretroviral therapy8-11,15. Therefore, 
the expansion of  a logical method to the screening and 
the successive management of  disease of  the cervix in 
this part of  population are essential.
Preceding practices in several Sub-Saharan countries un-
derlined the absence of  consistency of  cytology based 
cervical screening at the population level. The reasons 
were inadequate access to health services and lack of  
screening programs12. Hence, the impacts are directly vis-
ible on the poor’s, illiterates13.
Therefore, inexpensive cervical cancer screening tech-
niques based on visual inspection of  the cervix with Ace-
tic acid (VIA) or Visual Inspection with Lugol’s Iodine 
(VILI) have been planned and amended to resource-lim-
ited situations for years. In resource limited situations, 
VIA has revealed an equal strength compared to cytology. 
It is stated to have 80% sensitivity, 92% specificity, a 10% 
positive predictive value and a 99% negative predictive 
value14,31. Although screening of  pre-cancerous lesion 
of  the cervical (PCL) for women infected with HIV has 
been in progress in resource scarce centers in Ethiopia. 
Data on the prevalence and associated with the lesion is 
limited. Updated awareness about prevalence and asso-
ciated is needed to recognize women infected with HIV 
who are more likely to improve pre-cancerous lesion of  





An institution based cross-sectional study carried out in 
three referral hospitals the Amhara region of  Ethiopia 
from September 1st to December 30th, 2015.
Study setting
The Amhara region is one of  the nine states in Ethio-
pia. It is bounded by Tigray region to the North, Sudan 
to the West, the Afar region to the East, and the Benis-
hangul-Gumuz to the West and SouthWest, and Oromia 
region to the South. Based on the 2016 Ethiopian Demo-
graphic and health survey report, the prevalence of  HIV 
in Amhara region was 2.1%. The three referral hospitals 
(Debre Markos, Dessie and Felegehiwot) were included in 
the study. Each hospital provides care and treatment for 
more than 3,000 patients infected with HIV. Each referral 
hospital accepts an average of  80 women infected with 
HIV per day30.
Participants
Those HIV positive women who were visiting the ART 
clinic at the three hospitals and those HIV positive wom-
en who screened for pre-cancerous cervical lesion (PCL) 
recruited.
Women who were very ill and unable to answer ques-
tion swere excluded from the study. In addition, women 
who had  a history of  diagnosed cancer of  the cervix 
and those who had had total hysterectomy  were excluded 
from the study.
Sample size, sampling procedure and data collection 
A sample size of  435 was determined using single pop-
ulation proportion formula.  We used the Prevalence of  
22.1% pre-cancerous lesions of  the cervical among wom-
en infected with HIV in Southern Ethiopia22, a confidence 
interval (CI) of  95%, and marginal of  error 4% and 5% 
non-response rate. Since there were only three hospitals 
that provide the service, all of  them were selected pur-
posively. Systematic sampling technique was employed 
to select each participant. Women were interviewed at 
health institution using pre-tested and structured ques-
tionnaires. Four trained female BSc midwives collected 
the data. Two MSc midwives professionals were assigned 
as supervisor. Both data collectors and supervisors were 
trained on the purpose of  the study, data collection tech-
nique and tool before and after pre-test.
Trained midwives employed in the screening and treat-
ment centres of  the three hospitals conducted the screen-
ing for this study. Bi-valve speculum was placed into the 
vagina and the cervix visualized via a halogen focus lamp 
to recognize the squamo-columnar junction (SCJ).
After cleaning away any extra mucus with a cotton swab, a 
five percent acetic acid solution was applied to the cervix 
for VIA. The results were observable one minute after 
application.
Pre-cancerous cervical lesions were incorporated while 
dense aceto-white lesions with well defined margins de-
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tected in the vicinity of  the transformation zone initiating 
from the SCJ, or if  the whole cervix or cervical growth 
turned white. A notion of  invasive cancer of  the cervix 
was defined as any cervical ulcer or growth being ob-
served. Results of  VIA were categorized as negative, pos-
itive, or suspicious for invasive cancer of  the cervix (ICC) 
rendering to the International Agency for Research on 
Cancer (IARC) training manual. Whenever there was the
vagueness of  the screening outcome, the midwives dis-
cussed with a trained gynaecologist and he/she would 
approve the finding.
Operational definitions
Negative screening test of  pre-cancerous cervical lesion: 
No aceto white lesions on VIA which is normal cervix 
that remained pale and pink in colour.
Positive screening test of  pre-cancerous cervical lesion: 
Sharp, distinct, well-defined, dense aceto white areas 
close to the squamo-columnar junction on VIA.
Suspicion for pre-cancerous cervical lesion: any cer-
vical ulcer or growth being observed.
Data processing and analysis
Data was entered and analyzed using SPSS version 20. 
A frequency of  each variable was calculated to check for 
outliers and missed values. Proportion of  pre-cancerous 
lesion was determined. Logistic regression was done to 
analyze the data. Crude and adjusted Odds ratios were 
computed for each explanatory variable to determine the 
strength of  association and control confounders. P value 
< 0.2 was taken as a cut-off  point to select variables for 
the multiple logistic regression models. We used back-
ward elimination to avoid multi collinearity. A p-value of  
less than 0.05 was considered statistically significant.
Ethical consideration
The study was approved by the Ethical Review Commit-
tee of  university of  Gondar. Letter of  permission was 
taken from respective hospitals. Written consent (finger 
print for those who cannot read and write) was taken 
from every woman. Privacy and confidentiality was main-
tained throughout the study period by excluding personal 
identifiers from the data collection form.
Results
Sociodemographic characteristics
In total, 435 women were involved in the study making 
a response rate of  100%. The mean age of  the partic-
ipants was 35.9 years (SD = 4.5 years). More than half  
(53.6%) of  the participants were between 30 to 39 years 
old. Three hundred and fifty (80.5%) of  the respondents 
were Orthodox Christians and the majority (97.2%) were 
Amhara in Ethnicity. Three hundred seventy (85.1%) of  
them were urban dwellers and 175 (40.1%) had no formal 
education. More than half  (56.1%) of  the participants 
were married and nearly a quarter of  them (31%) were 
housewives. Two hundred seventy-eights (63.9%) of  the 
women had monthly income of  less than 33 USD Dollars 
per month per household with the median income of  28 
USD Dollars (Table 1).
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Reproductive health characteristics
The mean ages of  menarche was 14.62 (SD = 2.5) years. 
The mean age of  first sexual intercourse was 16.77 (SD 
= 2.7) years. Likewise, the mean age at first marriage was 
16.18 (SD = 3.81) years and mean age at first birth was 
16.77 (SD = 8.24) years. Three hundred five (71.3%) of  
the participants had their first sexual intercourse before 
the age of  18 years. More than half  (51.3%) of  the study 
participants had their first birth before the age of  18 
years. Two hundred fifty-five (58.60%) study participants 
had more than one lifetime sexual partners and more than 
three-fourth (87.1%) of  the participants had given birth 
at least once with the mean birth of  2.4 (SD = 2).Around 
one-third (30.1%) of  the participants had a history of  
abortion and 147 (33.8%) participants used contracep-
tives during the study period. Among the contraceptive 
methods, 84 (19.3%) used injectable contraceptive and 
189 (43.4%) used condom always and consistently during 
sexual intercourse. Nearly one-fourth (23%) of  the study 
participants had a history of  sexually transmitted disease 
(STD) and 47 (11.3%) of  them had history of  ulcerative 
genital lesions (Table 2).
Table 1: Distribution of study participants by their socio-demographic characteristic in 
Felege Hiwot referral hospital. Bahir dar city, NorthWest Ethiopia, September 1 2015 to 
December 30, 2015 (n = 265). 
 
Characteristics  Frequency  Percentage  Mean(SD) 
Age (in years)     35.6(4.2) 
20-29 54 12.4   
30-39 233 53.6   
≥40 148 34   
Marital status       
Single 24 5.5   
Married 224 56.1   
Divorced 98 22.5   
widowed 69 15.9   
Occupational status       
farmer  48 11   
housewife 138 31.7   
Gov employee 155 35.6   
daily laborer 94 21.6   
Educational status       
No formal education 175 40.1   
Grade 1-8 129 29.7   
Grade 9-12 82 18.9   
Above 12 49 11.3   
Residence       
Urban 370 85.1   
Rural 65 14.9   
Monthly income(birr)        
≤ 725  278 63.9   
726-1400 76 17.5   
1401-2350 39 9   
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Table 2 Reproductive health characteristics of study participants in Felege Hiwot referral 
hospital. Bahir dar city, Northwest Ethiopia 2015. 
   
Characteristics  Frequency  Percentage  Mean(SD) 
Age at first sexual intercourse     16.7(2.7) 
<18 305 70.1   
≥18 130 29.9   
Age at first marriage      16.18(3.87) 
<18 267 61.4   
≥18 168 38.6   
Age at first birth      16.77(8.24) 
<18 223 51.3   
≥18 212 48.7   
Life time number of sexual partners     3.9(3.5) 
1 75 17.2   
≥2 360 82.8   
Parity     2.4(2) 
0  56 12.9   
1-4 332 76.3   
≥5 47 10.8   
History of abortion     . 
yes 131 30.1   
No  304 69.9   
Family history of cervical cancer       
Yes  6 1.4   
No  429 98.6   
Use of condom during sexual 
intercourse 











Ever history of STD       
Yes  100 23   
No  335 77   
  
 Immunology, behavioral and other characteristics
Nearly all the participants (96.6%) were currently on ac-
tive anti-retroviral therapy (HAART). More than half  
(58.3%) of  the study participants had a baseline CD4 
count of  less than 200 copies/mm3 with the mean CD4 
count of  212 copies/mm3 (SD = 133.6). Most women 
(91.9%) had current CD4 counts of  200 copies/mm3 and 
above with the mean CD4 count of  479 copies/mm3 (SD 
= 203.9). The median duration of  HAART use was 36 
months and 11 (2.5%) participants had ever history of  
cigarette smoking (Table 3).
Prevalence of  precancerous cervical lesion of  the cervix
The prevalence of  pre-cancerous cervical lesion was 
20.2% 95% CI: 13%, 29%.
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Factors associated with precancerous cervical lesion
In the bivariate analysis, age, occupational status, educa-
tional status, age at first birth, history of  STD, lifetime 
number of  sexual partners, and baseline CD4 count were 
independently associated with pre-cancerous lesion of  
the cervix.
Multivariate logistic regression showed the age at first 
birth, number of  lifetime sexual partners, history of  
STD, and base line CD 4 count  statistically associated 
with pre-cancerous lesion of  the cervix. Mothers whose 
age at first birth less than 18 years were 3.36 times more 
likely to develop pre-cancerous cervical lesion than those 
whose age at first birth more than 18 years AOR=3.36, 
95% CI: 1.79,6.32. Those women infected with HIV who 
had more than one lifetime sexual partner were 2.91 times 
more likely to develop pre-cancerous  cervical lesion than 
those having one lifetime sexual partner AOR=2.91, 95% 
CI: 1.13,7.52.
Statistical association also depicted that those women 
who had a history of  STD were about 4.04 times more 
likely to have a pre-cancerous cervical lesion than those 
without a history of  STD AOR=4.04, 95% CI: 2.19, 7.44. 
Those women whose baseline CD4 count were less than 
200 cells/mm3 were 7.51 times more likely to have pre-
cancerous cervical lesions than those patients with a base-
line CD4 count above 200 cells/mm3 AOR=7.51, 95% 
CI 3.58,15.68 (Table 4).
Table 3 Immunological and behavioral characteristics of the study participants, in  
Felege Hiwot referral hospital. Bahir dar city, Northwest Ethiopia, 2016 (n=435). 
 
Characteristics  Frequency  Percentage  Mean(SD) 
Base line CD4 count before 
HAART  
    212.(133.6) 
<200 253 58.2   
≥200 182 41.8   
Recent CD4 count after HAART     479(203.9) 
<200 32 7.4   
≥200 403 92.6   
Current use of HAART       
Yes  420 96.6   
No  15 3.4   
ART clinic follow up duration       
1-6 months 416 95.6   
7-12months 19 4.4   
Current HAART use duration     Median=36month 
1-24 month 166 39.5   
25-48 month 111 26.4   
≥49 month 143 34   
Ever history of smoking       
Yes  11 2.5   
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Table 4 Logistic regression analysis of factors associated with precancerous cervical cancer 
lesion (PCCL) in Northwest Ethiopia, 2016. 
 
Characteristics   PCCL   COR(95%CI)  AOR(95%CI) P-
value  
  Yes  No        
Age          0.32 
20-29 8 48 1.00 1.00   
30-39 65 271 1.44(0.65,3.19) 1.51(0.52,4.39)   
≥40 15 28 3.21(1.21,8.53) 2.97(0.71,10)   
Occupational 
status  
        0.06 
Farmer  15 33 1.00 1.00   
House wife 30 108 0.61(0.29,1.27) 0.40(0.16,1.02)   
Govt employee 32 123 0.57(0.29,1.18) 0.44(0.17,1.11)   
daily laborer 11 83 0.29(0.12,0.70) 0.19(0.06,0.64)   
Educational 
status 
        0.10 
No formal 
education  
34 141 0.60(0.29,1.24) 0.82(0.26,2.59)   
Grade 1-8 31 98 0.79(0.38,1.66) 0.97(0.32,2.92)   
Grade 9-12 9 73 0.31(0.12,0.78) 0.33(0.10,1.09)   
Above 12 14 35 1.00 1.00   
Resident          0.38 
Urban 70 300 0.609(0.33,1.11)  1.57(0.57,4.44)   
Rural  18 47 1.00 1.00   
Age at first 
sexual 
intercourse 
        0.90 
<18 76 229 3.26(0.99, 2.52) 1.05(0.50,2.19)   
≥18 12 118 1.00 1.00   
Age at first 
birth 
        <0.001 
<18 64 159 3.15(1.89,5.27) 2.88(1.79,5.01)*   
≥18 24 188 1.00    ≥2 82 278 3.39(1.42,8.09) 2.91 (1.13,7.52)*   
History of 
abortion 
        0.68 
Yes  34 97 1.62(0.99,2.65) 0.86(0.41,1.73)   
No  54 250 1.00 1.00   
Ever history of 
STD 
        <0.001 
Yes  39 61 3.73(2.26,6.17) 3.04(2.19, 7.44)*   
No  49 286    
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Discussion
This study aimed to assess factors associated with pre-
cancerous cervical lesions among mothers who are HIV 
infected. The study shows that the overall prevalence of  
precancerous lesion of  the cervix among women infected 
with HIV in Amhara regional state referral hospitals was 
20.2%. This study is in line with studies carried out in 
Ukraine (21%)16 and Southern Ethiopia (22.1%)22. How-
ever, it is higher than the studies carried out in Republic 
of  Cote Devoir (10.6%)18 and West Nigeria (14.3%)19. 
The greater prevalence in this study could be due to the 
fact there are differences in the sexual practices of  the 
women studied. Having multiple sexual partners because 
of  cultural dissimilarities escalates the risk of  getting 
HPV, and in turn, the development of  cervical pre-cancer 
lesions. In Nigeria, where the lowest prevalence was stat-
ed, 96% of  the study participants had two or less lifetime 
sexual partners. In the current study, the mean number 
of  lifetime sexual partners is more than three. Also, the 
greater prevalence in this study could be due to the fact 
that there is a high chance of  younger age at first sexual 
intercourse. The mean age of  first sexual intercourse of  
study participants was 16.7 years, which could increase 
the number of  life time sexual partner and risk of  expo-
sure for pre-cancerous lesion of  the cervix.
This study illustrated that those mothers whose age at 
first birth less than 18 years were 3.36 times more like-
ly to develop pre-cancerous lesion of  the cervix com-
pared to those whose age at first birth more than 18 years 
AOR=3.36, 95%CI: 1.79,6.32. This is probably the first 
report of  any evidence that age at first birth less than 18 
years might contribute to the risk of  pre-cancerous lesion 
of  the cervix in women infected with HIV. Those wom-
en who gave birth less than 18 years would be at high 
exposure to HPV through early sexual intercourse and 
multiple sexual partners.
The present study also found that those women infected 
with HIV who had had more than one lifetime sexual 
partner were 2.91 times more likely to develop pre-can-
cerous lesion of  the cervix than those having one life-
time sexual partner AOR=2.91, 95%CI: 1.13,7.52. The 
result is similar with previous studies done in Nigeria26 
, Southern Ethiopia22 and Mekelle27. The possible expla-
nations might be those women who had more than one 
lifetime sexual partner could develop pre-cancerous cer-
vical lesion because of  as the number of  sexual partners 
increases they become more prone to acquiring the HPV 
infection, which is the causative agent for cervical cancer.
In this study those women who had ever history of  STD 
were about 4.04 times more likely to have a pre-cancerous 
lesion of  the cervix than those without a history of  STD 
AOR=4.04, 95% CI: 2.19, 7.44. This result is constant 
with studies conducted in Kenya28 and Southern Ethio-
pia22. The possible explanations might be because of  the 
sexually transmitted nature of  HPV infection. Co-infec-
tion with a STI like chlamydia trachomatis, herpes simplex or 
genital warts in the presence of  HPV amplified the risk 
of  CIN by causing inflammation which enables HPV te-
nacity and hence cervical lesion and carcinogenesis32.
Finally, the current study found that participants whose 
baseline CD4 count less than 200cells/mm3 were 7.51 
times more likely to have precancerous cervical lesion 
than those whose baseline CD4 count was more than 200 
cells/mm3 AOR=7.51, 95% CI 3.58,15.68. This finding
is consistent with studies done in Tanzania21 and Me-
kelle27. The possible explanations might be due to the 
effect of  immune function, HIV persuaded immunosup-
pression leads to incapability to control the HPV mani-
festation, the tenacity of  HPV infection and the progress 
of  cervical lesions.
This study didn’t show any association between PCL and 
currently not on HAART among HIV infected women. 
But studies conducted in Kenya20 and Southern Ethio-
pia22 stated the association between pre-cancerous le-
sion of  the cervix and not on HAART among women 
infected with HIV. The possible explanation might be in 
Southern Ethiopia 32% of  the study participants did not 
start HAART but in this study majority of  the study par-
ticipants (97%) started HAART. Therefore, in this study 
HAART might have prevented the development of  pre-
cancerous and invasive cancer and caused regression of  
the lesion31.
Limitation of  the study 
This study has some inherent limitations. The first one 
was those mothers who were asked about the number of  
sexual partners might have a chance of  social desirability 
bias. The second was the study involved only women who 
are infected with HIV voluntarily screened for PCL so 
that the generalizability of  results to all women infected 
with HIV in Amhara region might be inadequate. Fur-
thermore, the bias of  the visual screening methods might 
affect the study’s results in any direction.
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Conclusion
The prevalence of  pre-cancerous cervical lesion among 
women infected with HIV in Amhara regional state refer-
ral hospitals is higher which is a similar to the situation in 
resource limited countries. Age at first birth less 18 years, 
history of  lifetime STD, having more than one lifetime 
sexual partners were factors that were significantly asso-
ciated with pre-cancerous cervical lesion. Therefore, in-
creasing the limited screening and treatment centre is es-
sential to escalate access of  all women infected with HIV 
to the service. Moreover, actions intended at averting the 
acqusition and spread of  sexully transmitted disease and 
decreasing the number of  sexual partners are necessary. 
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